Cross-Market Thesis
“Skin cancer vaccine gains FDA approval”
This trader is expressing a view that Skin cancer vaccine FDA approved by December 31, 2027? are correlated outcomes, committing $1,610 to this thesis across 1 prediction market on Polymarket.
T
Trader_0x2128f69% win rate
Total
$1,610
Markets
1